Advertisement
Case Report| Volume 26, ISSUE 3, P229-231, September 2022

Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imaging

      Abstract

      Dextran has been frequently used during intracoronary imaging, such as in optical coherence tomography, optical frequent domain imaging, and coronary angioscopy. We report a case of dextran-induced anaphylaxis in a 70-year-old male with chronic coronary disease. Upon admission, we performed coronary angiography and coronary angioscopy on the patient. After the intracoronary imaging, the patient's blood pressure suddenly fell to 50 mmHg and a rash appeared on his chest. The patient was diagnosed as having dextran-induced anaphylactic shock. Epinephrine was administered repeatedly, and his blood pressure gradually recovered after administering a total of 6 mg epinephrine. There was no recurrence of the anaphylactic shock, and the patient was discharged 12 days later. The incidence of dextran-induced anaphylactic reactions is extremely low; however, they can be fatal. The possibility of anaphylactic shock induced by dextran should be kept in mind by all cardiovascular interventionalists performing intracoronary imaging.

      Learning objective

      Dextran has been frequently used during intracoronary imaging. We report on a case of dextran-induced anaphylaxis in a 70-year-old male with chronic coronary disease. While the incidence of dextran-induced anaphylactic reactions is extremely low, it can lead to fatal events. The possibility of anaphylactic shock induced by dextran should be kept in mind by all cardiovascular interventionalists while performing intracoronary imaging.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiology Cases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dai K.
        • Ishihara M.
        • Inoue I.
        • Kawagoe T.
        • Shimatani Y.
        • Kurisu S.
        • et al.
        Coronary angioscopic findings eight months after sirolimus-eluting stent implantation: a comparison between ST-elevation myocardial infarction and stable angina pectoris.
        EuroIntervention. 2010; 6: 251-256
        • Ljungstrom K.G.
        • Renck H.
        • Strandberg K.
        • Hedin H.
        • Richter W.
        • Widerlov E.
        Adverse reactions to dextran in Sweden 1970–1979.
        Acta Chir Scand. 1983; 149: 253-262
        • Paull J.D.
        Dextrans.
        Dev Biol Stand. 1987; 67: 133-138
        • Ljungstrom K.G.
        Pretreatment with dextran 1 makes dextran therapy safer.
        J Vasc Surg. 2006; 43: 1070-1072
        • Zinderman C.E.
        • Landow L.
        • Wise R.P.
        Anaphylactoid reactions to dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
        J Vasc Surg. 2006; 43: 1004-1009
        • Kabat E.A.
        • Turino G.M.
        • Tarrow A.B.
        • Maurer P.H.
        Studies on the immunochemical basis of allergic reactions to dextran in man.
        J Clin Invest. 1957; 36: 1160-1164
        • Yamagishi M.
        • Tamaki N.
        • Akasaka T.
        • Ikeda T.
        • Ueshima K.
        • Uemura S.
        • et al.
        JCS 2018 guideline on diagnosis of chronic coronary heart disease.
        Circ J. 2021; 85: 402-572